Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2012-09, Vol.56 (9), p.4870-4875 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4875 |
|---|---|
| container_issue | 9 |
| container_start_page | 4870 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 56 |
| creator | TASHIRO, Masato IZUMIKAWA, Koichi IMAMURA, Yoshifumi MIYAZAKI, Taiga NISHINO, Tomoya TSUKAMOTO, Misuzu KAKEYA, Hiroshi YAMAMOTO, Yoshihiro YANAGIHARA, Katsunori YASUOKA, Akira TASHIRO, Takayoshi KOHNO, Shigeru HIRANO, Katsuji IDE, Shotaro MIHARA, Tomo HOSOGAYA, Naoki TAKAZONO, Takahiro MORINAGA, Yoshitomo NAKAMURA, Shigeki KURIHARA, Shintaro |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/aac.00514-12 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_highw</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421857</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22751542</sourcerecordid><originalsourceid>FETCH-LOGICAL-a584t-ab4110ec686810adf01280dd2f10713aa0b9e6835bc498a3d2a3099a82ab33d13</originalsourceid><addsrcrecordid>eNp1ks1v1DAQxS0EotvCjTMyBw6VSBl_xOtckFYR0EqVOFDO1iRxdl059spOqJa_HpctBQ6cPJZ_fp73xoS8YnDBGNfvEfsLgJrJivEnZMWg0ZWqG_WUrACUqqQGeUJOc76Fsq8beE5OOF_XrJZ8RUIbU7IeZxcD7ex8Z22gN8nhj-htKSzOkw0zvXR5julAMQz065J7u59d57ybD9QF2noXXI_eH-hVjkXNDnST9zZtnfdLpuMyuS3OS35Bno3os335sJ6Rb58-3rSX1fWXz1ft5rrCWsu5wk4yBrZXWmkGOIxQnMIw8JHBmglE6BqrtKi7XjYaxcBRQNOg5tgJMTBxRj4cdfdLN9mhLxYSerNPbsJ0MBGd-fckuJ3Zxu9GSM50vS4C744CfYo5Jzs-3mVg7nM3m01rfuVuGC_4-RHHPHFzG5cUir3_sa__7u1R-PdQCvD2AcBcQh0Tht7lP5wSIFlz3-ObI7dz292dS9aU1035D6ZWpjFSr0H8BL7npeg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>TASHIRO, Masato ; IZUMIKAWA, Koichi ; IMAMURA, Yoshifumi ; MIYAZAKI, Taiga ; NISHINO, Tomoya ; TSUKAMOTO, Misuzu ; KAKEYA, Hiroshi ; YAMAMOTO, Yoshihiro ; YANAGIHARA, Katsunori ; YASUOKA, Akira ; TASHIRO, Takayoshi ; KOHNO, Shigeru ; HIRANO, Katsuji ; IDE, Shotaro ; MIHARA, Tomo ; HOSOGAYA, Naoki ; TAKAZONO, Takahiro ; MORINAGA, Yoshitomo ; NAKAMURA, Shigeki ; KURIHARA, Shintaro</creator><creatorcontrib>TASHIRO, Masato ; IZUMIKAWA, Koichi ; IMAMURA, Yoshifumi ; MIYAZAKI, Taiga ; NISHINO, Tomoya ; TSUKAMOTO, Misuzu ; KAKEYA, Hiroshi ; YAMAMOTO, Yoshihiro ; YANAGIHARA, Katsunori ; YASUOKA, Akira ; TASHIRO, Takayoshi ; KOHNO, Shigeru ; HIRANO, Katsuji ; IDE, Shotaro ; MIHARA, Tomo ; HOSOGAYA, Naoki ; TAKAZONO, Takahiro ; MORINAGA, Yoshitomo ; NAKAMURA, Shigeki ; KURIHARA, Shintaro</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/aac.00514-12</identifier><identifier>PMID: 22751542</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Aged ; Aged, 80 and over ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal Agents - administration & dosage ; Antifungal Agents - adverse effects ; Aspergillus fumigatus ; Aspergillus fumigatus - drug effects ; Aspergillus fumigatus - enzymology ; Aspergillus fumigatus - genetics ; Aspergillus fumigatus - isolation & purification ; Biological and medical sciences ; Cytochrome P-450 Enzyme System ; Cytochrome P-450 Enzyme System - genetics ; Cytochrome P-450 Enzyme System - metabolism ; Drug Resistance, Fungal ; Drug Resistance, Fungal - drug effects ; Drug Resistance, Fungal - genetics ; Female ; Fungal Proteins ; Fungal Proteins - genetics ; Fungal Proteins - metabolism ; Humans ; Itraconazole - administration & dosage ; Itraconazole - adverse effects ; Male ; Medical sciences ; Microbial Sensitivity Tests ; Middle Aged ; Mutation ; Pharmacology. Drug treatments ; Pulmonary Aspergillosis ; Pulmonary Aspergillosis - drug therapy ; Pulmonary Aspergillosis - microbiology ; Susceptibility ; Time Factors ; Triazoles - administration & dosage ; Triazoles - adverse effects</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4870-4875</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a584t-ab4110ec686810adf01280dd2f10713aa0b9e6835bc498a3d2a3099a82ab33d13</citedby><cites>FETCH-LOGICAL-a584t-ab4110ec686810adf01280dd2f10713aa0b9e6835bc498a3d2a3099a82ab33d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421857/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421857/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26304197$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22751542$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TASHIRO, Masato</creatorcontrib><creatorcontrib>IZUMIKAWA, Koichi</creatorcontrib><creatorcontrib>IMAMURA, Yoshifumi</creatorcontrib><creatorcontrib>MIYAZAKI, Taiga</creatorcontrib><creatorcontrib>NISHINO, Tomoya</creatorcontrib><creatorcontrib>TSUKAMOTO, Misuzu</creatorcontrib><creatorcontrib>KAKEYA, Hiroshi</creatorcontrib><creatorcontrib>YAMAMOTO, Yoshihiro</creatorcontrib><creatorcontrib>YANAGIHARA, Katsunori</creatorcontrib><creatorcontrib>YASUOKA, Akira</creatorcontrib><creatorcontrib>TASHIRO, Takayoshi</creatorcontrib><creatorcontrib>KOHNO, Shigeru</creatorcontrib><creatorcontrib>HIRANO, Katsuji</creatorcontrib><creatorcontrib>IDE, Shotaro</creatorcontrib><creatorcontrib>MIHARA, Tomo</creatorcontrib><creatorcontrib>HOSOGAYA, Naoki</creatorcontrib><creatorcontrib>TAKAZONO, Takahiro</creatorcontrib><creatorcontrib>MORINAGA, Yoshitomo</creatorcontrib><creatorcontrib>NAKAMURA, Shigeki</creatorcontrib><creatorcontrib>KURIHARA, Shintaro</creatorcontrib><title>Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal Agents - administration & dosage</subject><subject>Antifungal Agents - adverse effects</subject><subject>Aspergillus fumigatus</subject><subject>Aspergillus fumigatus - drug effects</subject><subject>Aspergillus fumigatus - enzymology</subject><subject>Aspergillus fumigatus - genetics</subject><subject>Aspergillus fumigatus - isolation & purification</subject><subject>Biological and medical sciences</subject><subject>Cytochrome P-450 Enzyme System</subject><subject>Cytochrome P-450 Enzyme System - genetics</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Drug Resistance, Fungal</subject><subject>Drug Resistance, Fungal - drug effects</subject><subject>Drug Resistance, Fungal - genetics</subject><subject>Female</subject><subject>Fungal Proteins</subject><subject>Fungal Proteins - genetics</subject><subject>Fungal Proteins - metabolism</subject><subject>Humans</subject><subject>Itraconazole - administration & dosage</subject><subject>Itraconazole - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary Aspergillosis</subject><subject>Pulmonary Aspergillosis - drug therapy</subject><subject>Pulmonary Aspergillosis - microbiology</subject><subject>Susceptibility</subject><subject>Time Factors</subject><subject>Triazoles - administration & dosage</subject><subject>Triazoles - adverse effects</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ks1v1DAQxS0EotvCjTMyBw6VSBl_xOtckFYR0EqVOFDO1iRxdl059spOqJa_HpctBQ6cPJZ_fp73xoS8YnDBGNfvEfsLgJrJivEnZMWg0ZWqG_WUrACUqqQGeUJOc76Fsq8beE5OOF_XrJZ8RUIbU7IeZxcD7ex8Z22gN8nhj-htKSzOkw0zvXR5julAMQz065J7u59d57ybD9QF2noXXI_eH-hVjkXNDnST9zZtnfdLpuMyuS3OS35Bno3os335sJ6Rb58-3rSX1fWXz1ft5rrCWsu5wk4yBrZXWmkGOIxQnMIw8JHBmglE6BqrtKi7XjYaxcBRQNOg5tgJMTBxRj4cdfdLN9mhLxYSerNPbsJ0MBGd-fckuJ3Zxu9GSM50vS4C744CfYo5Jzs-3mVg7nM3m01rfuVuGC_4-RHHPHFzG5cUir3_sa__7u1R-PdQCvD2AcBcQh0Tht7lP5wSIFlz3-ObI7dz292dS9aU1035D6ZWpjFSr0H8BL7npeg</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>TASHIRO, Masato</creator><creator>IZUMIKAWA, Koichi</creator><creator>IMAMURA, Yoshifumi</creator><creator>MIYAZAKI, Taiga</creator><creator>NISHINO, Tomoya</creator><creator>TSUKAMOTO, Misuzu</creator><creator>KAKEYA, Hiroshi</creator><creator>YAMAMOTO, Yoshihiro</creator><creator>YANAGIHARA, Katsunori</creator><creator>YASUOKA, Akira</creator><creator>TASHIRO, Takayoshi</creator><creator>KOHNO, Shigeru</creator><creator>HIRANO, Katsuji</creator><creator>IDE, Shotaro</creator><creator>MIHARA, Tomo</creator><creator>HOSOGAYA, Naoki</creator><creator>TAKAZONO, Takahiro</creator><creator>MORINAGA, Yoshitomo</creator><creator>NAKAMURA, Shigeki</creator><creator>KURIHARA, Shintaro</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120901</creationdate><title>Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus</title><author>TASHIRO, Masato ; IZUMIKAWA, Koichi ; IMAMURA, Yoshifumi ; MIYAZAKI, Taiga ; NISHINO, Tomoya ; TSUKAMOTO, Misuzu ; KAKEYA, Hiroshi ; YAMAMOTO, Yoshihiro ; YANAGIHARA, Katsunori ; YASUOKA, Akira ; TASHIRO, Takayoshi ; KOHNO, Shigeru ; HIRANO, Katsuji ; IDE, Shotaro ; MIHARA, Tomo ; HOSOGAYA, Naoki ; TAKAZONO, Takahiro ; MORINAGA, Yoshitomo ; NAKAMURA, Shigeki ; KURIHARA, Shintaro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a584t-ab4110ec686810adf01280dd2f10713aa0b9e6835bc498a3d2a3099a82ab33d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal Agents - administration & dosage</topic><topic>Antifungal Agents - adverse effects</topic><topic>Aspergillus fumigatus</topic><topic>Aspergillus fumigatus - drug effects</topic><topic>Aspergillus fumigatus - enzymology</topic><topic>Aspergillus fumigatus - genetics</topic><topic>Aspergillus fumigatus - isolation & purification</topic><topic>Biological and medical sciences</topic><topic>Cytochrome P-450 Enzyme System</topic><topic>Cytochrome P-450 Enzyme System - genetics</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Drug Resistance, Fungal</topic><topic>Drug Resistance, Fungal - drug effects</topic><topic>Drug Resistance, Fungal - genetics</topic><topic>Female</topic><topic>Fungal Proteins</topic><topic>Fungal Proteins - genetics</topic><topic>Fungal Proteins - metabolism</topic><topic>Humans</topic><topic>Itraconazole - administration & dosage</topic><topic>Itraconazole - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary Aspergillosis</topic><topic>Pulmonary Aspergillosis - drug therapy</topic><topic>Pulmonary Aspergillosis - microbiology</topic><topic>Susceptibility</topic><topic>Time Factors</topic><topic>Triazoles - administration & dosage</topic><topic>Triazoles - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TASHIRO, Masato</creatorcontrib><creatorcontrib>IZUMIKAWA, Koichi</creatorcontrib><creatorcontrib>IMAMURA, Yoshifumi</creatorcontrib><creatorcontrib>MIYAZAKI, Taiga</creatorcontrib><creatorcontrib>NISHINO, Tomoya</creatorcontrib><creatorcontrib>TSUKAMOTO, Misuzu</creatorcontrib><creatorcontrib>KAKEYA, Hiroshi</creatorcontrib><creatorcontrib>YAMAMOTO, Yoshihiro</creatorcontrib><creatorcontrib>YANAGIHARA, Katsunori</creatorcontrib><creatorcontrib>YASUOKA, Akira</creatorcontrib><creatorcontrib>TASHIRO, Takayoshi</creatorcontrib><creatorcontrib>KOHNO, Shigeru</creatorcontrib><creatorcontrib>HIRANO, Katsuji</creatorcontrib><creatorcontrib>IDE, Shotaro</creatorcontrib><creatorcontrib>MIHARA, Tomo</creatorcontrib><creatorcontrib>HOSOGAYA, Naoki</creatorcontrib><creatorcontrib>TAKAZONO, Takahiro</creatorcontrib><creatorcontrib>MORINAGA, Yoshitomo</creatorcontrib><creatorcontrib>NAKAMURA, Shigeki</creatorcontrib><creatorcontrib>KURIHARA, Shintaro</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TASHIRO, Masato</au><au>IZUMIKAWA, Koichi</au><au>IMAMURA, Yoshifumi</au><au>MIYAZAKI, Taiga</au><au>NISHINO, Tomoya</au><au>TSUKAMOTO, Misuzu</au><au>KAKEYA, Hiroshi</au><au>YAMAMOTO, Yoshihiro</au><au>YANAGIHARA, Katsunori</au><au>YASUOKA, Akira</au><au>TASHIRO, Takayoshi</au><au>KOHNO, Shigeru</au><au>HIRANO, Katsuji</au><au>IDE, Shotaro</au><au>MIHARA, Tomo</au><au>HOSOGAYA, Naoki</au><au>TAKAZONO, Takahiro</au><au>MORINAGA, Yoshitomo</au><au>NAKAMURA, Shigeki</au><au>KURIHARA, Shintaro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>56</volume><issue>9</issue><spage>4870</spage><epage>4875</epage><pages>4870-4875</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>22751542</pmid><doi>10.1128/aac.00514-12</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4870-4875 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3421857 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Aged Aged, 80 and over Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal Agents - administration & dosage Antifungal Agents - adverse effects Aspergillus fumigatus Aspergillus fumigatus - drug effects Aspergillus fumigatus - enzymology Aspergillus fumigatus - genetics Aspergillus fumigatus - isolation & purification Biological and medical sciences Cytochrome P-450 Enzyme System Cytochrome P-450 Enzyme System - genetics Cytochrome P-450 Enzyme System - metabolism Drug Resistance, Fungal Drug Resistance, Fungal - drug effects Drug Resistance, Fungal - genetics Female Fungal Proteins Fungal Proteins - genetics Fungal Proteins - metabolism Humans Itraconazole - administration & dosage Itraconazole - adverse effects Male Medical sciences Microbial Sensitivity Tests Middle Aged Mutation Pharmacology. Drug treatments Pulmonary Aspergillosis Pulmonary Aspergillosis - drug therapy Pulmonary Aspergillosis - microbiology Susceptibility Time Factors Triazoles - administration & dosage Triazoles - adverse effects |
| title | Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T10%3A03%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correlation%20between%20Triazole%20Treatment%20History%20and%20Susceptibility%20in%20Clinically%20Isolated%20Aspergillus%20fumigatus&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=TASHIRO,%20Masato&rft.date=2012-09-01&rft.volume=56&rft.issue=9&rft.spage=4870&rft.epage=4875&rft.pages=4870-4875&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/aac.00514-12&rft_dat=%3Cpubmed_highw%3E22751542%3C/pubmed_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22751542&rfr_iscdi=true |